Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Investigating the Suitability of Carbon Nanotube Reinforced Polymer in Transcatheter Valve Applications.

Rozeik MM, Wheatley DJ, Gourlay T.

Cardiovasc Eng Technol. 2017 Sep;8(3):357-367. doi: 10.1007/s13239-017-0313-2. Epub 2017 Jun 16.

2.

Percutaneous heart valves; past, present and future.

Rozeik MM, Wheatley DJ, Gourlay T.

Perfusion. 2014 Sep;29(5):397-410. doi: 10.1177/0267659114523464. Epub 2014 Mar 17. Review.

3.

The aortic valve: structure, complications and implications for transcatheter aortic valve replacement.

Rozeik M, Wheatley D, Gourlay T.

Perfusion. 2014 Jul;29(4):285-300. Epub 2014 Feb 25. Review.

4.

Guidelines on myocardial revascularization.

Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D.

Eur J Cardiothorac Surg. 2010 Sep;38 Suppl:S1-S52. doi: 10.1016/j.ejcts.2010.08.019. No abstract available.

5.

Guidelines on myocardial revascularization.

Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D.

Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277. Epub 2010 Aug 29. No abstract available.

6.

Microvascular preconditioning is not detectable by corrosion casting in the isolated perfused rat heart after 30 minutes of ischaemia.

Arangannal A, McGarrity A, Wheatley DJ, Belcher PR.

Scand Cardiovasc J. 2008 Feb;42(1):90-5. doi: 10.1080/14017430801918864.

PMID:
18273729
7.

Modelling chorded prosthetic mitral valves using the immersed boundary method.

Watton PN, Luo XY, Singleton R, Wang X, Bernacca GM, Molloy P, Wheatley DJ.

Conf Proc IEEE Eng Med Biol Soc. 2004;5:3745-8.

PMID:
17271109
8.

Our inability to predict thromboembolic events after prosthetic valve surgery.

Will MB, Bernacca GM, Bell EF, Tolland MM, Lowe GD, Rumley A, Murray HM, Ford I, Wheatley DJ.

J Heart Valve Dis. 2006 Jul;15(4):570-80; discussion 580.

PMID:
16901057
9.

Autologous blood transfusion for cardiopulmonary bypass: effects of storage conditions on platelet function.

Ramnarine IR, Higgins MJ, McGarrity A, Mahmood Z, Wheatley DJ, Belcher PR.

J Cardiothorac Vasc Anesth. 2006 Aug;20(4):541-7. Epub 2006 Feb 7.

PMID:
16884986
10.

Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.

Poole-Wilson PA, Pocock SJ, Fox KA, Henderson RA, Wheatley DJ, Chamberlain DA, Shaw TR, Clayton TC; Randomised Intervention Trial of unstable Angina Investigators.

Heart. 2006 Oct;92(10):1473-9. Epub 2006 Apr 18.

11.

Dynamic modelling of prosthetic chorded mitral valves using the immersed boundary method.

Watton PN, Luo XY, Wang X, Bernacca GM, Molloy P, Wheatley DJ.

J Biomech. 2007;40(3):613-26. Epub 2006 Apr 11.

PMID:
16584739
12.

5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, Knight R, Pocock SJ.

Lancet. 2005 Sep 10-16;366(9489):914-20.

PMID:
16154018
13.

The future role of surgery in ischaemic heart disease.

Wheatley DJ.

Surgeon. 2005 Jun;3(3):150-8. Review.

PMID:
16075999
14.

Fish oil before cardiac surgery: neutrophil activation is unaffected but myocardial damage is moderated.

Charman A, Muriithi EW, Milne E, Wheatley DJ, Armstrong RA, Belcher PR.

Prostaglandins Leukot Essent Fatty Acids. 2005 Apr;72(4):257-65.

PMID:
15763437
15.

The 'threshold age' in choosing biological versus mechanical prostheses in western countries.

Wheatley DJ.

J Heart Valve Dis. 2004 May;13 Suppl 1:S91-4. Review. No abstract available.

PMID:
15225016
16.

Clinical evaluation: statistical considerations and how to meet them in clinical practice.

Wheatley DJ.

J Heart Valve Dis. 2004 May;13 Suppl 1:S11-3. No abstract available.

PMID:
15224991
17.

Comparison of prosthetic valve hydrodynamic function: objective testing using statistical multilevel modeling.

Bernacca GM, McColl JH, Wheatley DJ.

J Heart Valve Dis. 2004 May;13(3):467-77.

PMID:
15222295
18.

Key developments in heart surgery.

Wheatley DJ.

Practitioner. 2004 Mar;248(1656):142-4, 146-8, 150-1 passim. Review. No abstract available.

PMID:
15024884
19.

Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses.

Oxenham H, Bloomfield P, Wheatley DJ, Lee RJ, Cunningham J, Prescott RJ, Miller HC.

Heart. 2003 Jul;89(7):715-21.

20.

Erythrocyte-containing versus crystalloid cardioplegia in the rat: effects on myocardial capillaries.

Chaudhry MA, Belcher PR, Day SP, Muriithi EW, Wheatley DJ.

Ann Thorac Surg. 2003 Mar;75(3):890-8.

PMID:
12645713
21.
22.

Are we negating the benefits of CABG by forgetting secondary prevention?

Belcher PR, Gaw A, Cooper M, Brown M, Wheatley DJ, Lindsay GM.

J Hum Hypertens. 2002 Oct;16(10):691-7.

23.

Coronary artery surgery at the dawn of the 21st century.

Wheatley DJ.

J R Coll Surg Edinb. 2002 Aug;47(4):608-12. Review.

PMID:
12363185
24.

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.

Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ; Randomized Intervention Trial of unstable Angina Investigators.

Lancet. 2002 Sep 7;360(9335):743-51.

PMID:
12241831
25.

Lipolysis generates platelet dysfunction after in vivo heparin administration.

Muriithi EW, Belcher PR, Day SP, Chaudhry MA, Caslake MJ, Wheatley DJ.

Clin Sci (Lond). 2002 Oct;103(4):433-40.

PMID:
12241544
26.

The potential of the heterotopic rat heart transplant model.

Wheatley DJ.

Transplantation. 2002 May 15;73(9):1382-3. No abstract available.

PMID:
12023611
27.

Mechanical and morphological study of biostable polyurethane heart valve leaflets explanted from sheep.

Bernacca GM, Straub I, Wheatley DJ.

J Biomed Mater Res. 2002 Jul;61(1):138-45.

PMID:
12001256
28.

Hydrodynamic function of polyurethane prosthetic heart valves: influences of Young's modulus and leaflet thickness.

Bernacca GM, O'Connor B, Williams DF, Wheatley DJ.

Biomaterials. 2002 Jan;23(1):45-50.

PMID:
11762853
29.

Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial.

McHugh F, Lindsay GM, Hanlon P, Hutton I, Brown MR, Morrison C, Wheatley DJ.

Heart. 2001 Sep;86(3):317-23.

30.
31.

Hydrodynamic function of a biostable polyurethane flexible heart valve after six months in sheep.

Wheatley DJ, Bernacca GM, Tolland MM, O'Connor B, Fisher J, Williams DF.

Int J Artif Organs. 2001 Feb;24(2):95-101.

PMID:
11256515
32.

A new design for polyurethane heart valves.

Butterfield M, Wheatley DJ, Williams DF, Fisher J.

J Heart Valve Dis. 2001 Jan;10(1):105-10.

PMID:
11206756
33.
34.
35.

Exercise intolerance following heart transplantation: the role of pulmonary diffusing capacity impairment.

Al-Rawas OA, Carter R, Stevenson RD, Naik SK, Wheatley DJ.

Chest. 2000 Dec;118(6):1661-70.

PMID:
11115456
36.

Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting.

Lindsay GM, Hanlon P, Smith LN, Wheatley DJ.

Eur J Cardiothorac Surg. 2000 Nov;18(5):557-64.

PMID:
11053817
37.

Evaluation of four blood pump geometries: the optical tracer technique.

Rose ML, Mackay TG, Martin W, Wheatley DJ.

Proc Inst Mech Eng H. 2000;214(4):371-83.

PMID:
10997058
38.

Evaluation of four blood pump geometries: fluorescent particle flow visualisation technique.

Rose ML, Mackay TG, Wheatley DJ.

Med Eng Phys. 2000 Apr;22(3):201-14.

PMID:
10964040
39.

The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.

Muriithi EW, Belcher PR, Rao JN, Chaudhry MA, Nicol D, Wheatley DJ.

J Thorac Cardiovasc Surg. 2000 Sep;120(3):538-43.

40.

Quantitative detection of platelet aggregates in whole blood without fixation.

Muriithi EW, Belcher PR, Menys VC, Chaudhry MA, Raco L, Day SP, Wheatley DJ.

Platelets. 2000 Feb;11(1):33-7.

PMID:
10938879
41.

Heparin-induced platelet dysfunction and cardiopulmonary bypass.

Muriithi EW, Belcher PR, Day SP, Menys VC, Wheatley DJ.

Ann Thorac Surg. 2000 Jun;69(6):1827-32.

PMID:
10892931
42.

Porcine versus pericardial bioprostheses: eleven-year follow up of a prospective randomized trial.

Chaudhry MA, Raco L, Muriithi EW, Bernacca GM, Tolland MM, Wheatley DJ.

J Heart Valve Dis. 2000 May;9(3):429-37; discussion 437-8.

PMID:
10888102
43.

Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass.

Belcher PR, Muriithi EW, Milne EM, Wanikiat P, Wheatley DJ, Armstrong RA.

Thromb Res. 2000 May 15;98(4):249-56.

PMID:
10822071
44.

Polyurethane: material for the next generation of heart valve prostheses?

Wheatley DJ, Raco L, Bernacca GM, Sim I, Belcher PR, Boyd JS.

Eur J Cardiothorac Surg. 2000 Apr;17(4):440-8.

PMID:
10773568
45.

Mechanisms of pulmonary transfer factor decline following heart transplantation.

Al-Rawas OA, Carter R, Stevenson RD, Naik SK, Wheatley DJ.

Eur J Cardiothorac Surg. 2000 Apr;17(4):355-61.

PMID:
10773555
46.
47.

Cardiothoracic surgery in Europe: politics, pressures and practice.

Wheatley DJ.

Eur J Cardiothorac Surg. 1999 Dec;16(6):593-601. No abstract available.

PMID:
10647826
48.

Can technetium 99m pyrophosphate be used to quantify myocardial injury in donor hearts?

Satur CM, Doyle D, Darracott-Cankovic S, Martin W, Wheatley DJ.

Ann Thorac Surg. 1999 Dec;68(6):2225-30.

PMID:
10617007
49.

Platelet aggregation and high-intensity transient signals (HITS) in a sheep model of mitral valve replacement.

Raco L, Belcher PR, Sim I, McGarrity A, Bernacca GM, Wheatley DJ.

J Heart Valve Dis. 1999 Sep;8(5):476-80; discussion 481.

PMID:
10517386

Supplemental Content

Loading ...
Support Center